Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 153566-98-4 | MDL No. : | MFCD12026392 |
Formula : | C7H13ClN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZMGVIBYONJXGRF-UHFFFAOYSA-N |
M.W : | 160.64 g/mol | Pubchem ID : | 49759129 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.86 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 47.08 |
TPSA : | 35.82 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.55 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 1.03 |
Log Po/w (WLOGP) : | 1.32 |
Log Po/w (MLOGP) : | 0.76 |
Log Po/w (SILICOS-IT) : | 1.36 |
Consensus Log Po/w : | 0.89 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.42 |
Solubility : | 6.12 mg/ml ; 0.0381 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.37 |
Solubility : | 6.82 mg/ml ; 0.0424 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.54 |
Solubility : | 4.68 mg/ml ; 0.0291 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.22 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With carbonochloridic acid 1-chloro-ethyl ester 1.) 1,2-dichloroethane, reflux, 4 h, 2.) CH3OH, reflux, 2 h; Yield given. Multistep reaction; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; In 1,4-dioxane; at 20℃; for 2h; | Step C: The nitrile prepared in Step B (3.12g, 13. 9MMOL) was dissolved in a solution OF 4N HCl/dioxane (100 ML) and stirred at rt for 2h before concentrating. The product was obtained as an HCl salt. ESI-MS calculated for C7H, 2N2 : 124.18, found 125 (M+H). | |
With hydrogenchloride; In 1,4-dioxane; at 20℃; for 2h; | Step C: The nitrile prepared in Step B (3.12 g, 13.9 mmol) was dissolved in a solution of 4N HCl/dioxane (100 mL) and stirred at rt for 2 h before concentrating. The product was obtained as an HCl salt. ESI-MS calculated for C7H12N2: 124.18. found 125 (M+H). | |
With hydrogenchloride; In 1,4-dioxane; water; for 1h; | In a round-bottomed flask, 13.4?mL of HCl in dioxane (4?M) was added 32 (400?mg, 1.78?mmol). After 1?h, Boc deprotection was completed and the solvent was removed under vacuum to afford 33 in quantitative yield. The crude material was used without further purification for the next step. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94% | With potassium carbonate; In acetonitrile; at 90℃; | The piperidine salt 33 (286 mg, 1.78 mmol) was dissolved in acetonitrile (70 mL), K2CO3 (307 mg, 2.22 mmol), 4-chloro-2,6-dimethoxyquinazoline (333 mg, 1.48 mmol) was added and stirred overnight at 90 C. The solvent was removed under vacuum and the product was purified by flash column chromatography using CH2Cl2/CH3OH (98:2) to afford 34 as a cream solid (436 mg, 94%). Mp: 64-65 C; IR (ATR, ZnSe): ν (cm-1) 2843, 1571, 1500, 1428, 1260, 1236, 1134, 1025, 928, 855; 1H NMR (400 MHz, CDCl3): δ (ppm) 8.67 (s, 1H), 7.24 (s, 1H), 7.07 (s, 1H), 4.20 (d, J = 13.3 Hz, 2H), 4.02 (s, 3H), 3.99 (s, 3H), 3.08 (t, J = 12.7 Hz, 2H), 2.42 (d, J = 6.2 Hz, 2H), 2.02 (m, 3H), 1.72-1.55 (m, 2H); 13C NMR (126 MHz, CDCl3): δ (ppm) 164.3, 154.7, 153.2, 149.3, 148.7, 118.2, 111.8, 107.7, 103.0, 56.4, 56.2, 49.9, 33.7, 31.5, 24.3; HRMS-ESI calcd for C17H24N4O2 [M+H]+ 317.1972 found 317.1972. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: potassium carbonate / acetonitrile / 90 °C 2: hydrogen; palladium 10% on activated carbon; lithium hydroxide monohydrate / water; 1,4-dioxane / 22 h / 2550.26 Torr |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: pyridine; trifluoroacetic anhydride / tetrahydrofuran / 5 h / 0 - 20 °C 2: hydrogenchloride / 1,4-dioxane / 2 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: ammonia / dichloromethane / 0.08 h 2: pyridine; trifluoroacetic anhydride / tetrahydrofuran / 5 h / 0 - 20 °C 3: hydrogenchloride / 1,4-dioxane / 2 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: triethylamine / dichloromethane / 0.25 h / 0 - 20 °C 2: ammonia / dichloromethane / 0.08 h 3: pyridine; trifluoroacetic anhydride / tetrahydrofuran / 5 h / 0 - 20 °C 4: hydrogenchloride / 1,4-dioxane / 2 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | With N-ethyl-N,N-diisopropylamine In acetonitrile at 60℃; for 1h; | 21 Compound 20R-e (164mg, 0.32mmol) was dissolved in acetonitrile (5mL),Then 2-(piperidin-4-yl)acetonitrile hydrochloride (1R-e, 51mg, 0.32mmol) and diisopropylethylamine (124mg, 0.96mmol) were added sequentially. The reaction mixture was stirred at 60°C for 1 hour.TLC monitors the completion of the reaction. The reaction mixture was concentrated under reduced pressure. The obtained crude product was separated and purified by silica gel column chromatography (dichloromethane:methanol=30:1) to obtain a pale yellow solid compound 20R-f(160mg, yield 83%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76% | With N-ethyl-N,N-diisopropylamine In acetonitrile at 60℃; for 3h; | 22 Compound 21S-e (100 mg, 0.24 mmol) and compound 1R-e (59 mg, 0.48 mmol) were dissolved in acetonitrile (5 mL), and diisopropylethylamine (0.28 mL, 1.68 mmol) was added dropwise.The reaction mixture was stirred at 60°C for 3 hours. TLC monitors the completion of the reaction.The reaction mixture was concentrated under reduced pressure. The obtained crude product is subjected to preparative thin plate chromatography(Dichloromethane:methanol=30:1) separated and purified to obtain a yellow solid compound 21S-f(92mg, yield 76%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77% | With N-ethyl-N,N-diisopropylamine In acetonitrile at 60℃; for 3h; | 1 Compound 1R-d (145mg, 0.37mmol) was dissolved in acetonitrile (10mL),Then 2-(piperidin-4-yl)acetonitrile hydrochloride (1R-e, 72mg, 0.45mmol) and diisopropylethylamine (144mg, 1.11mmol) were added sequentially. The reaction mixture was stirred at 60°C for 3 hours.TLC monitors the completion of the reaction. The reaction mixture was concentrated under reduced pressure.The obtained crude product was subjected to silica gel column chromatography (dichloromethane: ethyl acetate = 30:1)After separation and purification, a light yellow solid compound 1R-f (136 mg, yield 77%) was obtained. |
[ 240401-22-3 ]
Piperidine-4-carbonitrile hydrochloride
Similarity: 0.96
[ 5562-23-2 ]
2-(Piperidin-3-yl)acetonitrile hydrochloride
Similarity: 0.96
[ 202002-66-2 ]
2-(Piperidin-4-yl)acetonitrile
Similarity: 0.95
[ 1258638-34-4 ]
2-Methyl-2-(piperidin-4-yl)propanenitrile hydrochloride
Similarity: 0.92
[ 948894-26-6 ]
4-Methylpiperidine-4-carbonitrile hydrochloride
Similarity: 0.92
[ 240401-22-3 ]
Piperidine-4-carbonitrile hydrochloride
Similarity: 0.96
[ 5562-23-2 ]
2-(Piperidin-3-yl)acetonitrile hydrochloride
Similarity: 0.96
[ 202002-66-2 ]
2-(Piperidin-4-yl)acetonitrile
Similarity: 0.95
[ 1258638-34-4 ]
2-Methyl-2-(piperidin-4-yl)propanenitrile hydrochloride
Similarity: 0.92
[ 948894-26-6 ]
4-Methylpiperidine-4-carbonitrile hydrochloride
Similarity: 0.92